Company Filing History:
Years Active: 2013-2016
Title: Sunil Chavan: Innovator in Fused Bicyclic Imidazoles
Introduction
Sunil Chavan is a notable inventor based in Nashik, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of fused bicyclic imidazoles. With a total of 2 patents to his name, Chavan's work focuses on compounds that have the potential to inhibit critical biological pathways.
Latest Patents
Chavan's latest patents include innovative compounds of formula (I), which are described as effective inhibitors of the Pi3K/Akt pathway. These compounds, which can exist as tautomers or stereoisomers, demonstrate promising applications in therapeutic settings. The specific configurations of ring B and the imidazole to which it is fused, along with the substituents R4, R6, and R7, are detailed in the claims of his patents.
Career Highlights
Sunil Chavan is currently associated with Bayer Intellectual Property GmbH, where he continues to advance his research in the pharmaceutical domain. His work is characterized by a commitment to developing innovative solutions that address complex health challenges.
Collaborations
Chavan collaborates with esteemed colleagues such as Swen Hölder and Armin Zülch, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Sunil Chavan's contributions to the field of medicinal chemistry, particularly through his patents on fused bicyclic imidazoles, highlight his role as a key innovator. His ongoing work at Bayer Intellectual Property GmbH promises to yield further advancements in therapeutic applications.